Exon-specific differences observed for GLI1 in the discovery cohort were consistent with previously reported alternative transcription of this gene in basal cell carcinoma [23] and the lack of detection in previous studies performed on previous HNSCC array studies [35]–[39]. This evidence concerns the gene GLI1 and head and neck squamous cell carcinoma.